Comments on efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil

被引：1
|
作者：
McRae, TD [1 ]
Schwam, EM [1 ]
机构：
[1] Pfizer Inc, Alzheimers Dis Management Team, New York, NY 10017 USA
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2002年 / 18卷 / 06期
关键词：
D O I：
10.1185/030079902125000949
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I / III
页数：3
相关论文
共 50 条
  • [1] Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    Auriacombe, S
    Pere, JJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : IV - VI
  • [2] Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    Auriacombe, S
    Pere, JJ
    Loria-Kanza, Y
    Vellas, B
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (03) : 129 - 138
  • [3] Rivastigmine may benefit patients with Alzheimer's disease (AD) who have failed to benefit from previous donepezil treatment
    Grossberg, G
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 262 - 262
  • [4] No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment
    Auriacombe, S
    Pere, JJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) : 715 - 717
  • [5] Tolerability, safety and efficacy in patients with Alzheimer's disease who are switched from donepezil to galantamine
    Kurz, AF
    Gold, M
    NEUROBIOLOGY OF AGING, 2004, 25 : S202 - S203
  • [6] Metaanalysis of randomized trials of the efficacy and safety of Donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease
    Ritchie, CW
    Ames, D
    Clayton, T
    Lai, R
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (04): : 358 - 369
  • [7] Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis
    Hansen, Richard A.
    Gartlehner, Gerald
    Webb, Aaron P.
    Morgan, Laura C.
    Moore, Charity G.
    Jonas, Daniel E.
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 211 - 225
  • [8] Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients
    Zhang, Nan
    Gordon, Marc L.
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 1963 - 1970
  • [9] Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment
    Dantoine, T
    Auriacombe, S
    Sarazin, M
    Becker, H
    Pere, JJ
    Bourdeix, I
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (01) : 110 - 118
  • [10] Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Tan, Chen-Chen
    Yu, Jin-Tai
    Wang, Hui-Fu
    Tan, Meng-Shan
    Meng, Xiang-Fei
    Wang, Chong
    Jiang, Teng
    Zhu, Xi-Chen
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (02) : 615 - 631
12345